Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype Jose M. GarciaJose M. SilvaFelix Bonilla OriginalPaper Pages: 237 - 243
Biomarkers for local recurrence after breast‐conservation — a nested case‐control study K. DalbergE. ErikssonL.E. Rutqvist OriginalPaper Pages: 245 - 259
Anti‐human procathepsin D activation peptide antibodies inhibit breast cancer development Vaclav VetvickaJana VetvickovaMartin Fusek OriginalPaper Pages: 261 - 269
Antimetastatic effect of desmopressin in a mouse mammary tumor model Daniel F. AlonsoGuillermo SkiltonDaniel E. Gomez OriginalPaper Pages: 271 - 275
Tamoxifen and fenretinide in women with metastatic breast cancer J. ZujewskiL. PaiJ.A. O'Shaughnessy OriginalPaper Pages: 277 - 283
Changes in body composition during breast cancer chemotherapy with the CMF‐regimen A. AslaniR.C. SmithJ.A. Levi OriginalPaper Pages: 285 - 290
Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors Richard J. Barth Jr. OriginalPaper Pages: 291 - 295
